The ordinary general meeting of Nile Co. for Pharmaceuticals & Chemical Industries ratified on Saturday, September 20 the board’s report, and financial statements for the fiscal year that ended on June 30, 2014.
Shareholders also approved the proposed dividend distribution for FY13/14 at EGP 0.73 per share.
The company’s financial results for the fiscal year that ended on June 30, 2014 had mirrored EGP 17 million net profit, with a decline by 23% compared with EGP 22.3 million a year earlier.
The company had generated EGP 12.9 million distributable net profit in the 11-month period till May 31, 2014, with a fall by 41% compared with EGP 22 million in the year-ago period.